chapter 2 basic principles Flashcards
agonist-cell receptor relationship
-fits like lock and key to produce pharmacological response
antagonist-receptor relationship (blockers)
- interferes with naturally occurring agonists or drugs
- incapable of producing biological effect
down-regulation/desensitization
- responsiveness decreases
- occurs when continually stimulated receptors
- due to decreased number of available receptors or change in existing receptors
- can ultimately result in lack of response to drug
up-regulation/hypersensitization
- receptor’s activity chronically reduced from antagonists
- if antagonists rapidly stopped receptors will exaggerate natural agonists response
therapeutic index
- relationship btwn therapeutic effects and adverse effects
- ratio of doses required to produce death/serious toxicity in 50% of pts versus doses required to produce effective treatment for 50% of pts.
- index is “wide”-drug safe and no need for close monitoring
- index is “narrow”-close monitoring needed
drug effect
- result of interaction between target cell/receptor to produce therapeutic effect
- usually temporary and reversible
- drug-receptor binding very specific (lock and key)
- usually graded-larger the dose the greater the effect
onset of action
- time needed for drug concentration to reach minimum level
- changes with manner of administration (i.e. IV, IM)
time to peak
-time required for maximum effect after administration
duration of action
- blood levels are above minimum effective concentration
- not effected by route of administration
termination of action
-drug level drops below minimum effective concentration
drug efficacy
-measured by maximum effect that drug can achieve
drug potency
- compares doses of two different drugs required to achieve same effect
- influenced by absorption, distribution, metabolism, and excretion
i. e 10mg rosuvarstatin = 20mg atorvaststin–rosuvarstatin is more potent
drug absorption
- passive diffusion-no energy, usually in GI tract, only nonionized lipid soluble drugs work well
- active transport-needs energy. usually opposite concentration gradient, uses absorption of electrolytes and pinocytosis (i.e. fat soluble drugs like vitamins)
- IV-begins distribution immediately
- IM/SQ-must undergo absorption from injection site; affected by blood flow@ site of injection
- PO: empty v. Full stomach;
- chelation-usually supplement that binds with drug and not free to be absorbed
first-pass metabolism
-ONLY FOR PO MEDS
-metabolism in liver of part of drug before it reaches systemic circulation
-IV and sublingual don’t use portal circulation
-PO-absorbed in stomach and then move to liver via portal vein
-the > amount of drug absorbed via first-pass the > dose
-drugs the large first metabolism:
dopamine, lidocaine, propanolol, imipramine, morphine, reserpine, nitro, isoproterenol, warfarin
enterohepatic recycling
- some drugs leave liver circulation and enter biliary tract to be excreted in bile eventually being available for reabsorption through intestinal wall
- bile reabsorbs every 80 days and therefore drug could re-circulate for a long time